Whitestone REIT Declares Fourth Quarter 2020 Dividends
HOUSTON, Sept. 22, 2020 (GLOBE NEWSWIRE) — Whitestone REIT’s (NYSE:WSR) (“Whitestone” or the “Company”) Board of Trustees has declared a […]
Astec Industries Announces Investor Day
CHATTANOOGA, Tenn., Sept. 22, 2020 (GLOBE NEWSWIRE) — Astec Industries, Inc. (Nasdaq: ASTE) announces today that it will host an […]
Alpha Healthcare Acquisition Corp. Announces Closing of $100,000,000 Initial Public Offering
New York, NY, Sept. 22, 2020 (GLOBE NEWSWIRE) — Alpha Healthcare Acquisition Corp. (NASDAQ: AHACU) (the “Company”) announced today that […]
Simmons First National Corporation Announces Third Quarter Earnings Release Date and Conference Call
PINE BLUFF, Ark., Sept. 22, 2020 (GLOBE NEWSWIRE) — Simmons First National Corp. (NASDAQ: SFNC) today announced it expects to […]
HC2 Holdings Announces Record Date for Rights Offering
NEW YORK, Sept. 22, 2020 (GLOBE NEWSWIRE) — HC2 Holdings, Inc. (“HC2” or the “Company”) (NYSE: HCHC), a diversified holding […]
Zogenix, Inc. Announces Proposed Convertible Senior Notes Offering
EMERYVILLE, Calif., Sept. 22, 2020 (GLOBE NEWSWIRE) — Zogenix, Inc. (Nasdaq: ZGNX) today announced its intention to offer, subject to […]
Usio Announces Proposed Public Offering of Common Stock
SAN ANTONIO, Sept. 22, 2020 (GLOBE NEWSWIRE) — Usio, Inc. (Nasdaq: USIO), an integrated electronic payment solutions provider, today announced […]
Stitch Fix Announces Fourth Quarter and Full Fiscal Year 2020 Financial Results
SAN FRANCISCO, Sept. 22, 2020 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, has released […]
Athira Pharma Announces Closing of Initial Public Offering
SEATTLE, Sept. 22, 2020 (GLOBE NEWSWIRE) — Athira Pharma, Inc., (Nasdaq: ATHA) (“Athira”), a late clinical-stage biopharmaceutical company focused on […]
SpringWorks Therapeutics to Participate in H.C. Wainwright Precision Oncology Investor Conference
STAMFORD, Conn., Sept. 22, 2020 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing […]
